Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHILL: Therapeutic Hypothermia in ARDS
NCT04545424Phase 2Active, not recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Jun 2021
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Ventilator-Free Days at 28 days. Started Jun 2021; status: active, not recruiting.
02
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04545424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545424.